Lincoln National Corp’s Guardant Health GH Stock Holding History

Lincoln National Corp’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,416	Closed	-$302K	–	906
2021 Q3	$302K	Hold	2,416	–	–	0.01%	674
2021 Q2	$300K	Buy	2,416 +2	+0.1%	+$269	0.01%	664
2021 Q1	$368K	Sell	2,414 -53	-2%	-$8.01K	0.01%	546
2020 Q4	$318K	Hold	2,467	–	–	0.01%	560
2020 Q3	$276K	Buy	+2,467	New	+$226K	0.01%	536

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Lincoln National Corp's GH Position: Q4 2021 in Review

Lincoln National Corp sold out of Guardant Health (GH) in Q4 2021, closing a stake of 2,416 shares — an estimated $302K sold.

Lincoln National Corp first reported a position in GH in Q3 2020 and held it in 5 quarters. The position peaked at $368K in Q1 2021. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

Lincoln National Corp reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
Lincoln National Corp sold 2,416 Guardant Health shares in Q4 2021, an estimated $302K.
Lincoln National Corp first reported a position in Guardant Health in Q3 2020 and held it in 5 quarters.
Lincoln National Corp's Guardant Health position peaked at $368K in Q1 2021.
396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on Lincoln National Corp's 13F filing for Q4 2021, filed 26 Jan 2022.